

          1. Participation in other investigational clinical trials for the treatment or prevention
             of SARS-COV-2 infection within 30days

          2. Unwilling to practice acceptable methods of birth control (both males who have
             partners of childbearing potential and females of childbearing potential) during
             Screening, while taking study drug, and for at least 30 days after the last dose of
             study drug is ingested Note: the following criteria follow standard clinical practice
             for FDA approved indications of this medication

          3. Having a prior history of blood disorders such as aplastic anemia, agranulocytosis,
             leukopenia, or thrombocytopenia

          4. Having a prior history of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency

          5. Having dermatitis, psoriasis or porphyria

          6. Taking Digoxin, Mefloquine, methotrexate, cyclosporine, praziquantel, antacids and
             kaolin, cimetidine, ampicillin, Insulin or antidiabetic drugs, arrhythmogenic drugs,
             antiepileptic drugs, loop, thiazide, and related diuretics, laxatives and enemas,
             amphotericin B, high dose corticosteroids, and proton pump inhibitors, neostigmine,
             praziquantel, Pyridostigmine, tamoxifen citrate

          7. Allergies: 4-Aminoquinolines

          8. Pre-existing retinopathy of the eye

          9. Has a chronic liver disease or cirrhosis, including hepatitis B and/or untreated
             hepatitis

         10. Untreated or uncontrolled active bacterial, fungal infection

         11. Known or suspected active drug or alcohol abuse, per investigator judgment

         12. Women who are pregnant or breastfeeding

         13. Known hypersensitivity to any component of the study drug

         14. A known history of prolonged QT syndrome or history of additional risk factors for
             torsades de pointe (e.g., heart failure, requires a lab test , family history of Long
             QT Syndrome), or the use of concomitant medications that prolong the QT/QTc interval
      